Your browser doesn't support javascript.
loading
MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6.
Lin, Mao; Xue, Xiang-Yang; Liang, Shu-Zhen; Li, Yin-Xiong; Lv, You-Yong; He, Li-Hua; Xu, Ke-Cheng; Zhang, Li-Fang; Chen, Ji-Bing; Niu, Li-Zhi.
Affiliation
  • Lin M; Fuda Cancer Hospital, Jinan University School of Medicine, Department of Central Laboratory, Guangzhou, China.
  • Xue XY; Wenzhou Medical University, Department of Immunology and Microbiology, Wenzhou, China.
  • Liang SZ; Fuda Cancer Hospital, Jinan University School of Medicine, Department of Central Laboratory, Guangzhou, China.
  • Li YX; Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Lv YY; Peking University Cancer Hospital, Department of Central Laboratory, Beijing, China.
  • He LH; Fuda Cancer Hospital, Jinan University School of Medicine, Department of Central Laboratory, Guangzhou, China.
  • Xu KC; Fuda Cancer Hospital, Jinan University School of Medicine, Department of Central Laboratory, Guangzhou, China.
  • Zhang LF; Wenzhou Medical University, Department of Immunology and Microbiology, Wenzhou, China.
  • Chen JB; Fuda Cancer Hospital, Jinan University School of Medicine, Department of Central Laboratory, Guangzhou, China.
  • Niu LZ; Fuda Cancer Hospital, Jinan University School of Medicine, Department of Central Laboratory, Guangzhou, China.
Oncotarget ; 8(38): 62914-62926, 2017 Sep 08.
Article in En | MEDLINE | ID: mdl-28968959
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: China